Barclays »

Avita Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-12-31 $525k 41k 12.80
2024-09-30 $402k 38k 10.72
2024-06-30 $68k 8.5k 7.98
2024-03-31 $325k 20k 15.98
2023-12-31 $473k 35k 13.72
2023-09-30 $63k 4.3k 14.53
2023-06-30 $85k 5.0k 16.97
2022-06-30 $0 90 0.00
2022-03-31 $34k 3.9k 8.62